Skip to main content
    C

    Caris Life Sciences, Inc. Common Stock (CAI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $31.76
    +1.51 (+4.97%)

    Market Cap: $8.55B

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    60%(3/5)
    Avg Surprise
    -542.71%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.02
    Range$-0.01 - $0.07
    10 analysts
    EPS Revisions
    3
    0
    7d
    3
    6
    30d
    EPS Estimate DriftChange to current
    90d ago$0.04-49.3%
    60d ago$0.03-19.3%
    30d ago$0.03-25.3%
    7d ago$0.03-15.3%
    Current$0.02
    Revenue Consensus
    $255M
    Range$243M - $263M
    13 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.12
    Range$0.02 - $0.25
    11 analysts
    Revenue Consensus
    $327M
    Range$302M - $332M
    14 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    -$0.12---
    Sep 26EST
    -$0.02---
    Jun 26
    Reported Aug 5
    $-0.54$-0.01-5300.00%Miss+51.4%
    Mar 26
    Reported May 7
    $-0.00N/A+91.00%Beat+99.5%
    Dec 25
    Reported Feb 26
    $0.28$0.01+2700.00%Beat-
    Sep 25
    Reported Nov 5
    $0.08$-0.08+200.00%Beat-
    Jun 25
    Reported Aug 12
    $-1.11$-0.22-404.55%Miss-
    Mar 25
    Reported May 28
    $-0.35$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-174.70EV/EBITDAN/A
    Price/FCF72.48xFCF Yield1.38%
    Profitability
    Profit Margin10.60%Operating Margin10.20%
    ROE20.10%ROICN/A
    Financial Health
    Debt/Equity0.66xInterest CoverageN/A
    Current Ratio5.53xQuick Ratio4.88x
    Trading Statistics
    BetaN/AAvg Volume5.00M
    52-Week High$33.1352-Week Low$14.19

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$29.17
    SMA 20$30.10
    SMA 50$26.86
    SMA 200$21.27
    EMA 10$29.80
    EMA 20$29.26
    EMA 50$26.72
    EMA 200$23.29

    MACD

    Line: 0.92Signal: 1.03Hist: -0.11

    ADX

    ADX: 37.2+DI: 34.0-DI: 12.0

    Aroon & PSAR

    Aroon Up36.0
    Aroon DownN/A
    PSAR$25.98

    Bollinger Bands

    Upper Band$33.36
    Lower Band$26.84
    %B Position2167%(Upper)
    Band Width0.75

    RSI (14-Day)

    Neutral
    62.7

    Momentum Oscillators

    Stoch %K68.2
    Stoch %D59.7
    Williams %R-12.0
    ROC (10d)12.0%
    Momentum3.41
    CCI (20d)42.8
    MFI (14d)45.8

    Volatility Measures

    ATR (14d)$1.92(6.1%)
    StdDev (20d)1.63
    Hist Vol66.8%(High)

    Volume Flow

    VWAP$30.90
    OBV-18.5M
    AD Line9.6M
    CMF (20d)0.047

    Volume Metrics

    Avg Vol (20d)4.9M
    Vol Ratio0.7x
    VWMA (20d)$30.09

    Pivot Points

    R3$34.02
    R2$32.78
    R1$31.52
    Pivot Point$30.27
    S1$29.01
    S2$27.76
    S3$26.50

    Advanced Oscillators

    TSI14.56
    Ultimate Osc67.6
    KST119.54

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Sep 2024Jun 2024Mar 2024Sep 2021Jun 2021Mar 2021
    Total Revenue$263.71M$216.17M$292.89M$216.83M$181.40M$120.92M$101.62M$100.05M$80.68M$100.83M$85.69M$80.80M
    Cost of Revenue$84.12M$74.83M$71.97M$69.33M$67.71M$63.85M$57.21M$62.49M$54.56M$46.74M$42.83M$42.21M
    Gross Profit$179.60M$141.35M$220.91M$147.51M$113.69M$57.06M$44.41M$37.55M$26.11M$54.09M$42.87M$38.59M
    Operating Expenses$152.67M$136.07M$132.50M$114.86M$131.67M$115.01M$105.25M$104.56M$118.34M$12.29M$10.17M$7.74M
    R&D$32.36M$31.32M$31.84M$21.62M$25.05M$23.07M$27.64M$24.79M$34.38M$0$0$0
    SG&A$66.55M$59.71M$56.51M$51.97M$64.37M$52.12M$40.85M$41.07M$45.47M$12.29M$10.17M$7.74M
    Operating Income$26.93M$5.28M$88.41M$32.64M$-17,989,000$-57,952,000$-60,842,000$-67,011,000$-92,225,000$66.44M$50.84M$48.76M
    Interest Income$6.82M$6.83M$7.01M$7.36M$1.62M$503,000$1.74M$2.64M$1.77M$0$0$0
    Interest Expense$9.23M$12.81M$11.36M$13.51M$19.21M$12.78M$13.80M$13.67M$9.29M$11.61M$11.11M$11.17M
    Income Before Tax$-614,000$-644,000$81.96M$24.32M$-71,790,000$-102,581,000$-67,729,000$-66,186,000$-111,028,000$54.83M$39.80M$37.18M
    Income Tax Expense$23,000$-134,000$0$0$0$0$0$0$0$3.68M$1.86M$2.50M
    Net Income$-637,000$-510,000$81.96M$24.32M$-71,790,000$-102,581,000$-67,729,000$-66,186,000$-111,028,000$51.16M$37.94M$35.74M
    EBITDA$8.63M$13.02M$97.60M$37.80M$-40,036,000$-81,312,000$-43,316,000$-55,152,000$-84,033,000$87.72M$80.39M$77.12M
    EBIT$1.79M$5.33M$93.31M$30.47M$-54,200,000$-90,302,000$-55,674,000$-55,152,000$-101,738,000$54.83M$50.91M$48.35M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CAI

    CAI Valuation and Fair Value

    P/E
    -174.7x
    Forward P/E
    43.3x
    P/FCF
    72.5x
    P/B
    15.2x
    See GNG's fair value

    CAI Profitability: Margins, ROIC and FCF

    Gross margin
    69.7%
    Operating margin
    10.2%
    Net margin
    10.6%
    ROE
    20.1%
    FCF margin
    12.5%
    FCF yield
    1.4%

    CAI Analyst Ratings

    Consensus
    Buy
    Analysts
    14
    Strong Buy
    1
    Buy
    9
    Hold
    4
    Sell
    0
    Strong Sell
    0

    CAI Bull Case vs Bear Case

    Bull case

    • CAI grew quarterly revenue 45.4% year over year.
    • 71.4% of CAI's analyst ratings are Buy or Strong Buy.

    CAI Earnings: Beat Rate and Next Report

    Beat rate
    3 of 6 quarters (50.0%)
    Average surprise
    -542.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.02
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    3 up, 6 down

    Frequently Asked Questions About CAI

    Does CAI pay dividends?

    Caris Life Sciences, Inc. Common Stock (CAI) does not currently pay a regular dividend.

    What is CAI's market cap?

    Caris Life Sciences, Inc. Common Stock (CAI) has a market capitalization of $8.55B with a current stock price of $31.76.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.